These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 33427637)

  • 1. [Guillain-Barré syndrome associated with SARS-CoV-2].
    Chapon F
    Med Sci (Paris); 2020 Dec; 36 Hors série n° 2():53-54. PubMed ID: 33427637
    [No Abstract]   [Full Text] [Related]  

  • 2. SARS-CoV-2 Infection and Guillain-Barré Syndrome: A Review on Potential Pathogenic Mechanisms.
    Shoraka S; Ferreira MLB; Mohebbi SR; Ghaemi A
    Front Immunol; 2021; 12():674922. PubMed ID: 34040615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiganglioside antibodies in Guillain-Barré syndrome associated with SARS-CoV-2 infection.
    Civardi C; Collini A; Geda DJ; Geda C
    J Neurol Neurosurg Psychiatry; 2020 Dec; 91(12):1361-1362. PubMed ID: 32859744
    [No Abstract]   [Full Text] [Related]  

  • 4. Post SARS-CoV-2 Guillain-Barré syndrome.
    Arnaud S; Budowski C; Ng Wing Tin S; Degos B
    Clin Neurophysiol; 2020 Jul; 131(7):1652-1654. PubMed ID: 32422529
    [No Abstract]   [Full Text] [Related]  

  • 5. [The first Hungarian patient with Guillain-Barre syndrome after COVID-19].
    Al-Muhanna N; Béres-Molnár AK; Jarecsny T; Folyovich A
    Ideggyogy Sz; 2021 Jan; 74(1-2):64-66. PubMed ID: 33497053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Guillain-Barré Syndrome Associated with SARS-CoV-2.
    Toscano G; Palmerini F; Ravaglia S; Ruiz L; Invernizzi P; Cuzzoni MG; Franciotta D; Baldanti F; Daturi R; Postorino P; Cavallini A; Micieli G
    N Engl J Med; 2020 Jun; 382(26):2574-2576. PubMed ID: 32302082
    [No Abstract]   [Full Text] [Related]  

  • 7. SARS-CoV-2 associated Guillain-Barré syndrome.
    Pelea T; Reuter U; Schmidt C; Laubinger R; Siegmund R; Walther BW
    J Neurol; 2021 Apr; 268(4):1191-1194. PubMed ID: 32770414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19-induced Guillain-Barre Syndrome: A Rare Complication of SARS-CoV-2 Infection.
    Hanif M; Khan AW; Khan MA; Sundas F; Khan SJ
    J Coll Physicians Surg Pak; 2021 Jul; 31(7):S123-S124. PubMed ID: 34271810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SARS-CoV-2-related Guillain-Barré syndrome requires comprehensive diagnostic and therapeutic care.
    Finsterer J
    J Med Life; 2024 Jan; 17(1):126. PubMed ID: 38737653
    [No Abstract]   [Full Text] [Related]  

  • 10. Guillain-Barré syndrome during SARS-CoV-2 pandemic: A case report and review of recent literature.
    Scheidl E; Canseco DD; Hadji-Naumov A; Bereznai B
    J Peripher Nerv Syst; 2020 Jun; 25(2):204-207. PubMed ID: 32388880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Guillain-Barre syndrome associated with COVID-19].
    Bogdanova AA; Kravtsunova ES; Raevskaia AI; Karpov AS; Gadaborshev RN; Dzutsev AI; Vyshlova IA; Karpov SM
    Zh Nevrol Psikhiatr Im S S Korsakova; 2022; 122(9):132-136. PubMed ID: 36168699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Guillain-Barré syndrome in the COVID-19 era: another occasional cluster?
    Tatu L; Nono S; Grácio S; Koçer S
    J Neurol; 2021 Apr; 268(4):1198-1200. PubMed ID: 32577868
    [No Abstract]   [Full Text] [Related]  

  • 13. A case report of Guillain-Barré syndrome in a pregnant woman infected by COVID-19.
    Mehrpour M; Arab M; Hadavand F; Khalafi M; Khalafi M
    Acta Neurol Belg; 2021 Aug; 121(4):1079-1080. PubMed ID: 34080170
    [No Abstract]   [Full Text] [Related]  

  • 14. Letter to the Editor: Finger Extensor Weakness Is Not a Novel Clinical Feature of SARS-CoV-2 Associated Guillain-Barre Syndrome.
    Finsterer J
    J Korean Med Sci; 2022 Jul; 37(27):e223. PubMed ID: 35818707
    [No Abstract]   [Full Text] [Related]  

  • 15. Guillain-Barré syndrome after SARS-CoV-2 infection.
    Kilinc D; van de Pasch S; Doets AY; Jacobs BC; van Vliet J; Garssen MPJ
    Eur J Neurol; 2020 Sep; 27(9):1757-1758. PubMed ID: 32533876
    [No Abstract]   [Full Text] [Related]  

  • 16. [SARS-CoV-2, a new causal agent of Guillain-Barre syndrome].
    Redondo-Urda MJ; Rodríguez-Peguero FJ; Pérez-Gil O; Del Valle-Sánchez M; Carrera-Izquierdo M
    Rev Neurol; 2020 Oct; 71(7):275-276. PubMed ID: 32959360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19-associated Guillain-Barre syndrome: Postinfectious alone or neuroinvasive too?
    Khan F; Sharma P; Pandey S; Sharma D; V V; Kumar N; Shukla S; Dandu H; Jain A; Garg RK; Malhotra HS
    J Med Virol; 2021 Oct; 93(10):6045-6049. PubMed ID: 34170552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Response to: SARS-CoV-2 associated Guillain-Barré syndrome in 62 patients.
    Doneddu PE; De Sanctis P; Viganò L; Selmi C; Gentile F; Nobile-Orazio E
    Eur J Neurol; 2021 Jan; 28(1):e9. PubMed ID: 32978868
    [No Abstract]   [Full Text] [Related]  

  • 19. SARS-CoV-2 associated Guillain-Barre syndrome after awaking on the ICU: consider differentials.
    Finsterer J
    Tuberk Toraks; 2021 Sep; 69(3):429-430. PubMed ID: 34581168
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharyngeal-Cervical-Brachial Variant of Guillain-Barré Syndrome: A Rare SARS-CoV-2 Infection-Associated Neurological Complication.
    Kapoor D; Sharma S; Anand A
    Indian J Pediatr; 2022 Sep; 89(9):942. PubMed ID: 35852703
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.